Introduction {#Sec1}
============

The optimal target temperature for comatose patients resuscitated from out of hospital cardiac arrest is unknown. It has been hypothesized that patients with long no-flow times, for example those without bystander CPR would have the most to gain from temperature management at lower temperatures \[[@CR1]\]. The generalizability of the TTM-trial \[[@CR2]\] has been questioned because of a high fraction of patients receiving bystander cardiopulmonary resuscitation (CPR) (73%) and a median start of basic life support (for patients with bystander CPR) of 1 minute (Interquartile range 1-2 minutes).

Objectives {#Sec2}
==========

The aim of this study was to explore any potential interaction between temperature and no-flow time to investigate whether patients who had longer periods of cerebral ischemia had a better response to the lower target temperature of 33°C in the TTM-trial \[[@CR2]\].

Methods {#Sec3}
=======

We analysed data from an international clinical trial randomizing cardiac arrest patients to targeted temperature management at 33°C and 36°C for an interaction between no-flow time and intervention group, with neurological function at 180 days after cardiac arrest as the primary outcome. A cerebral performance category (CPC) score of 1 or 2 was considered a good outcome. The interaction term was included in a multivariate logistic model adjusting for design variables in the TTM-trial.

Results {#Sec4}
=======

The interaction between no-flow time and temperature group was not significant. Adjusted predictions showed no difference in the probability of a good neurological outcome for any value of no-flow time (Fig 1). In the group of patients with more than eight minutes of no-flow time the difference in the average predicted probability of a poor outcome was -0.018 (95% CI -0.17 - 0.13, p = 0.81) i.e. a non-significant decrease of 1.8% in the probability of a poor neurological outcome for patients treated at 36°C.

Conclusions {#Sec5}
===========

The neutral effect of the two temperature levels was consistent for all no-flow times.

The hypothesis that the efficacy of target temperature at 33°C vs. 36°C is influenced by no-flow time could not be supported.
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